Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-24-129751
Filing Date
2024-11-21
Accepted
2024-11-21 16:38:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 424b3_engene_form_s-3_no.htm 424B3 251796
2 GRAPHIC img24710649_0.jpg GRAPHIC 87857
3 GRAPHIC img24710649_1.jpg GRAPHIC 7738
  Complete submission text file 0000950170-24-129751.txt   384726
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 424B3 | Act: 33 | File No.: 333-283201 | Film No.: 241485005
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)